Boehringer Ingelheim Animal Health

2:45 PM - 3:00 PM (PDT), Tuesday, June 14, 2022
Boehringer Ingelheim Animal Health is a global leader in the animal health industry and part of the family-owned Boehringer Ingelheim company founded in 1885.

Our innovation approach builds on our track record of developing transformative therapeutics, parasiticides and vaccines that have significantly contributed to improving animal health and well-being. We also go beyond medicine to better predict, detect and prevent animal diseases before they arise.

We believe that diversity of thought is the key to new knowledge and knowledge is the catalyst for innovation. Collaborations with partners who share our passion for improving the health and wellbeing of animals play an essential role in our ambition to find solutions to the biggest challenges in animal health. By working together we can learn more, do more and achieve more, and accelerate the development of the next generation of breakthroughs.
Company Type:
Privately Funded Company
Company HQ State:
Not Provided
Company HQ Country:
Germany
Year Founded:
1885
Main Therapeutic Focus:
Lead Product in Development:
Multiple Products in Pipeline
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
BD & L
Boehringer Ingelheim Animal Health GmbH